{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:46:15Z","timestamp":1769582775478,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,11,26]],"date-time":"2005-11-26T00:00:00Z","timestamp":1132963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s10038-005-0321-1","type":"journal-article","created":{"date-parts":[[2005,11,25]],"date-time":"2005-11-25T08:28:11Z","timestamp":1132907291000},"page":"1-8","source":"Crossref","is-referenced-by-count":118,"title":["Recent advances in the molecular basis of Lafora\u2019s progressive myoclonus epilepsy"],"prefix":"10.1038","volume":"51","author":[{"given":"Subramaniam","family":"Ganesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchi","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,26]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.0013-9580.2004.33203.x","volume":"45","author":"G Annesi","year":"2004","unstructured":"Annesi G, Sofia V, Gambardella A, Candiano IC, Spadafora P, Annesi F, Cutuli N, De Marco EV, Civitelli D, Carrideo S, Tarantino P, Barone R, Zappia M, Quattrone A (2004) A novel exon 1 mutation in a patient with atypical Lafora progressive myoclonus epilepsy seen as childhood-onset cognitive deficit. Epilepsia 45:294\u2013295","journal-title":"Epilepsia"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/ni0102-20","volume":"3","author":"Y Ben-Neriah","year":"2002","unstructured":"Ben-Neriah Y (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3:20\u201326","journal-title":"Nat Immunol"},{"key":"321_CR3","first-page":"1","volume":"6","author":"HLSM Busard","year":"1987","unstructured":"Busard HLSM, Renier WO, Gabreels FJM, Jasper HHJ, Slooff JL, Janssen AJM, van Haelst UJG (1987) Lafora disease: a quantitative morphological and biochemical study of the cerebral cortex. Clin Neuropathol 6:1\u20136","journal-title":"Clin Neuropathol"},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0165-0173(99)00003-X","volume":"29","author":"JB Cavanagh","year":"1999","unstructured":"Cavanagh JB (1999) Corpora-amylacea and the family of polyglucosan diseases. Brain Res Rev 29:265\u2013295","journal-title":"Brain Res Rev"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/jmg.40.9.671","volume":"40","author":"EM Chan","year":"2003","unstructured":"Chan EM, Bulman DE, Paterson AD, Turnbull J, Andermann E, Andermann F, Rouleau GA, Delgado-Escueta AV, Scherer SW, Minassian BA (2003a) Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J Med Genet 40:671\u2013675","journal-title":"J Med Genet"},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/ng1238","volume":"35","author":"EM Chan","year":"2003","unstructured":"Chan EM, Young EJ, Ianzano L, Munteanu I, Zhao X, Christopoulos CC, Avanzini G, Elia M, Ackerley CA, Jovic NJ, Bohlega S, Andermann E, Rouleau GA, Delgado-Escueta AV, Minassian BA, Scherer SW (2003b) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 35:125\u2013127","journal-title":"Nat Genet"},{"key":"321_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/01.WNL.0000133215.65836.03","volume":"63","author":"EM Chan","year":"2004","unstructured":"Chan EM, Omer S, Ahmed M, Bridges LR, Bennett C, Scherer SW, Minassian BA (2004a) Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology 63:565\u2013567","journal-title":"Neurology"},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/hmg\/ddh130","volume":"13","author":"EM Chan","year":"2004","unstructured":"Chan EM, Ackerley CA, Lohi H, Ianzano L, Cortez MA, Shannon P, Scherer SW, Minassian BA (2004b) Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Hum Mol Genet 13:1117\u20131129","journal-title":"Hum Mol Genet"},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajmg.1575","volume":"106","author":"AV Delgado-Escueta","year":"2001","unstructured":"Delgado-Escueta AV, Ganesh S, Yamakawa K (2001) Advances in the genetics of progressive myoclonus epilepsy. Am J Med Genet 106:129\u2013138","journal-title":"Am J Med Genet"},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1093\/hmg\/ddg340","volume":"12","author":"ME Fernandez-Sanchez","year":"2003","unstructured":"Fernandez-Sanchez ME, Criado-Garcia O, Heath KE, Garcia-Fojeda B, Medrano-Fernandez I, Gomez-Garre P, Sanz P, Serratosa JM, Rodriguez de Cordoba S (2003) Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum Mol Genet 12:3161\u20133171","journal-title":"Hum Mol Genet"},{"key":"321_CR11","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/oxfordjournals.hmg.a018916","volume":"9","author":"S Ganesh","year":"2000","unstructured":"Ganesh S, Agarwala KL, Ueda K, Akagi T, Shoda K, Usui T, Hashikawa T, Osada H, Delgado-Escueta AV, Yamakawa K (2000) Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual specificity phosphatase associated with polyribosomes. Hum Mol Genet 9:2251\u20132261","journal-title":"Hum Mol Genet"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/mcpr.2001.0371","volume":"15","author":"S Ganesh","year":"2001","unstructured":"Ganesh S, Shoda K, Amano K, Uchiyama A, Kumuda S, Moriyama N, Hirose S, Yamakawa K (2001a) Mutation screening for Japanese Lafora\u2019s disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of the EPM2A gene. Mol Cell Probes 15:281\u2013289","journal-title":"Mol Cell Probes"},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1006\/bbrc.2001.4914","volume":"283","author":"S Ganesh","year":"2001","unstructured":"Ganesh S, Agarwala KL, Amano K, Suzuki T, Delgado-Escueta AV, Yamakawa K (2001b) Regional and developmental expression of Epm2a gene and its evolutionary conservation. Biochem Biophys Res Commun 283:1046\u20131053","journal-title":"Biochem Biophys Res Commun"},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/hmg\/11.11.1263","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Suzuki T, Francheschetti S, Riggio C, Avanzini G, Rabinowicz A, Bohlega S, Bailey J, Alonso ME, Rasmussen A, Ochoa A, Prado AJ, Medina MT, Yamakawa K (2002a) Genotype\u2013phenotype correlations for EPM2A mutations in Lafora\u2019s progressive myoclonus epilepsy: exon 1 mutations associate with an early onset cognitive deficit subphenotype. Hum Mol Genet 11:1263\u20131271","journal-title":"Hum Mol Genet"},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1006\/bbrc.2002.6590","volume":"1291","author":"S Ganesh","year":"2002","unstructured":"Ganesh S, Suzuki T, Yamakawa K (2002b) Alternative splicing modulates subcellular localization of laforin. Biochem Biophys Res Commun 1291:1134\u20131137","journal-title":"Biochem Biophys Res Commun"},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Avila MR, Sakamoto T, Machado-Salas J, Hoshii Y, Akagi T, Suzuki T, Amano K, Agarwala KL, Hasegawa Y, Ishihara T, Hashikawa T, Itohara S, Cornford EM, Niki H, Yamakawa K (2002c) Targeted disruption of Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 11:1251\u20131262","journal-title":"Hum Mol Genet"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/hmg\/ddg253","volume":"12","author":"S Ganesh","year":"2003","unstructured":"Ganesh S, Tsurutani N, Suzuki T, Ueda K, Agarwala KL, Osada H, Delgado-Escueta AV, Yamakawa K (2003) The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain. Hum Mol Genet 12:2359\u20132368","journal-title":"Hum Mol Genet"},{"key":"321_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.bbrc.2003.12.043","volume":"31","author":"S Ganesh","year":"2004","unstructured":"Ganesh S, Tsurutani N, Suzuki T, Hoshii Y, Ishihara T, Deldago-Escueta AV, Yamakawa K (2004) The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem Biophys Res Commun 31:1101\u20131109","journal-title":"Biochem Biophys Res Commun"},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2005.07.002","volume":"387","author":"S Ganesh","year":"2005","unstructured":"Ganesh S, Tsurutani N, Amano K, Mittal S, Uchikawa C, Delgado-Escueta AV, Yamakawa K (2005) Transcriptional profiling of a mouse model for Lafora disease reveals dysregulation of genes involved in the expression and modification of proteins. Neurosci Lett 387:62\u201367","journal-title":"Neurosci Lett"},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.1073\/pnas.0503285102","volume":"102","author":"MS Gentry","year":"2005","unstructured":"Gentry MS, Worby CA, Dixon JE (2005) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci USA 102:8501\u20138506","journal-title":"Proc Natl Acad Sci USA"},{"key":"321_CR21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","volume":"64","author":"C Gomez-Abad","year":"2005","unstructured":"Gomez-Abad C, Gomez-Garre P, Gutierrez-Delicado E, Saygi S, Michelucci R, Tassinari CA, Rodriguez de Cordoba S, Serratosa JM (2005) Lafora disease due to EPM2B mutations: a clinical and genetic study. Neurology 64:982\u2013986","journal-title":"Neurology"},{"key":"321_CR22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.ejhg.5200571","volume":"8","author":"P Gomez-Garre","year":"2000","unstructured":"Gomez-Garre P, Sanz Y, Rodriguez De Cordoba SR, Serratosa JM (2000) Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions. Eur J Hum Genet 8:946\u2013954","journal-title":"Eur J Hum Genet"},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0888-7543(03)00094-6","volume":"81","author":"L Ianzano","year":"2003","unstructured":"Ianzano L, Zhao XC, Minassian BA, Scherer SW (2003) Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product. Genomics 81:579\u2013587","journal-title":"Genomics"},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/humu.10306","volume":"23","author":"L Ianzano","year":"2004","unstructured":"Ianzano L, Young EJ, Zhao XC, Chan EM, Rodriguez MT, Torrado MV, Scherer SW, Minassian BA (2004) Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy. Hum Mutat 23:170\u2013176","journal-title":"Hum Mutat"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s100380300006","volume":"48","author":"CS Ki","year":"2003","unstructured":"Ki CS, Kong SY, Seo DW, Hong SB, Kim HJ, Kim JW (2003)Two novel mutations in the EPM2A gene in a Korean patient with Lafora\u2019s progressive myoclonus epilepsy. J Hum Genet 48:51\u201354","journal-title":"J Hum Genet"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1093\/hmg\/ddi306","volume":"14","author":"H Lohi","year":"2005","unstructured":"Lohi H, Ianzano L, Zhao XC, Chan EM, Turnbull J, Scherer SW, Ackerley CA, Minassian BA (2005a) Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum Mol Genet 14:2727\u20132736","journal-title":"Hum Mol Genet"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/science.1102832","volume":"307","author":"H Lohi","year":"2005","unstructured":"Lohi H, Young EJ, Fitzmaurice SN, Rusbridge C, Chan EM, Vervoort M, Turnbull J, Zhao XC, Ianzano L, Paterson AD, Sutter NB, Ostrander EA, Andre C, Shelton GD, Ackerley CA, Scherer SW, Minassian BA (2005b) Expanded repeat in canine epilepsy. Science 307:81","journal-title":"Science"},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/2470","volume":"20","author":"BA Minassian","year":"1998","unstructured":"Minassian BA, Lee JR, Herbrick JA, Huizenga J, Soder S, Mungall AJ, Dunham I, Gardner R, Fong CY, Carpenter S, Jardim L, Satishchandra P, Andermann E, Snead OC III, Lopes-Cendes I, Tsui LC, Delgado-Escueta AV, Rouleau GA, Scherer SW (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20:171\u2013174","journal-title":"Nat Genet"},{"key":"321_CR29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1212\/WNL.55.3.341","volume":"55","author":"BA Minassian","year":"2000","unstructured":"Minassian BA, Ianzano L, Meloche M, Andermann E, Rouleau GA, Delgado-Escueta AV, Scherer SW (2000a) Mutation spectrum and predicted function of laforin in Lafora\u2019s progressive myoclonus epilepsy. Neurology 55:331\u2013333","journal-title":"Neurology"},{"key":"321_CR30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.54.2.488","volume":"54","author":"BA Minassian","year":"2000","unstructured":"Minassian BA, Ianzano L, Delgado-Escueta AV, Scherer SW (2000b) Identification of new and common mutations in the EPM2A gene in Lafora disease. Neurology 54:488\u2013490","journal-title":"Neurology"},{"key":"321_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/brain\/103.2.315","volume":"103","author":"Y Robitaille","year":"1980","unstructured":"Robitaille Y, Carpenter S, Karpati G, DiMauro SD (1980) A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora\u2019s disease and normal ageing. Brain 103:315\u2013336","journal-title":"Brain"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1086\/301596","volume":"61","author":"J Sainz","year":"1997","unstructured":"Sainz J, Minassian BA, Serratosa JM, Gee MN, Sakamoto LM, Iranmanesh R, Bohlega S, Baumann RJ, Ryan S, Sparkes RS, Delgado-Escueta AV (1997) Lafora progressive myoclonus epilepsy: narrowing the chromosome 6q24 locus by recombinations and homozygosities. Am J Hum Genet 61:1205\u20131205","journal-title":"Am J Hum Genet"},{"key":"321_CR33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.20.2.160","volume":"20","author":"M Sakai","year":"1970","unstructured":"Sakai M, Austin J, Witmer F, Trueb L (1970) Studies in myoclonus epilepsy (Lafora body form) II polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology 20:160\u2013176","journal-title":"Neurology"},{"key":"321_CR34","first-page":"800","volume":"28","author":"GA Schwartz","year":"1965","unstructured":"Schwartz GA, Yanoff (1965) Lafora bodies, corpora-amylacea, and Lewy bodies: morphological and histochemical study. Arch Neurobiol 28:800\u2013818","journal-title":"Arch Neurobiol"},{"key":"321_CR35","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/hmg\/4.9.1657","volume":"4","author":"JM Serratosa","year":"1995","unstructured":"Serratosa JM, Delgado-Escueta AV, Posada I, Shih S, Drury I, Berciano J, Zabala JA, Antunez MC, Sparkes RS (1995) The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Genet 4:1657\u20131663","journal-title":"Hum Mol Genet"},{"key":"321_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/hmg\/8.2.345","volume":"8","author":"JM Serratosa","year":"1999","unstructured":"Serratosa JM, Gomez-Garre P, Gallardo ME, Anta B, de Bernabe DB, Lindhout D, Augustijn PB, Tassinari CA, Malafosse RM, Topcu M, Grid D, Dravet C, Berkovic SF, de Cordoba SR (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8:345\u2013352","journal-title":"Hum Mol Genet"},{"key":"321_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10038-005-0263-7","volume":"50","author":"S Singh","year":"2005","unstructured":"Singh S, Suzuki T, Uchiyama A, Kumada S, Moriyama N, Hirose S, Takahashi Y, Inoue Y, Kimura K, Sawaishi S, Yamakawa K, Ganesh S (2005) Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population. J Hum Genet 50:347\u2013352","journal-title":"J Hum Genet"},{"key":"321_CR38","unstructured":"Van Heycop Ten Ham MW (1975) Lafora disease, a form of progressive myoclonus epilepsy. In: Vinken PJ, Bruyn GW (eds) The epilepsies. Handbook of clinical neurology 15. North-Holland, Amsterdam, pp\u00a0382\u2013422"},{"key":"321_CR39","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1074\/jbc.C100686200","volume":"277","author":"J Wang","year":"2002","unstructured":"Wang J, Stuckey JA, Wishart MJ, Dixon JE (2002) A unique carbohydrate binding domain targets the Lafora disease phosphatase to glycogen. J Biol Chem 277:2377\u20132380","journal-title":"J Biol Chem"},{"key":"321_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0009-8981(75)90093-5","volume":"62","author":"S Yokoi","year":"1975","unstructured":"Yokoi S, Nakayama H, Negishi T (1975) Biochemical studies on tissues from a patient with Lafora disease. Clin Chim Acta 62:415\u2013423","journal-title":"Clin Chim Acta"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg20061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg20061","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg20061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T19:34:40Z","timestamp":1638387280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg20061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s10038-005-0321-1","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,26]]}}}